Finally, He et al. recently showed that HDAC inhibition may also suppress the proliferation, migration and invasion of HPV-negative HNSCC cells through the selective action of HDAC inhibitors on the EGFR-ADP ribosylation factor (Arf1) complex axis [32]. The gene discussed is ARF1; the disease is head and neck squamous cell carcinoma.